These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18475450)

  • 1. Synthesis of a new biological response modifier thyrnosin beta(4) analogue and its restorative effect on depressed.
    Abiko T; Sekino H
    Mediators Inflamm; 1992; 1(2):113-9. PubMed ID: 18475450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2467-71. PubMed ID: 2605693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional roles of Phe of deacetyl-thymosin beta4 in the impaired blastogenic response of uraemic T-lymphocytes.
    Abiko T; Sekino H
    Mediators Inflamm; 1997; 6(1):64-8. PubMed ID: 18472836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):221-37. PubMed ID: 8292971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of a thymosin beta 4-like peptide, thymosin beta Met9, and its effect on low E-rosette-forming lymphocytes of lupus nephritis patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2301-4. PubMed ID: 2279297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of two deacetyl-thymosin alpha(1) analogues and their effects on low E-rosette-forming lymphocytes of uraemic patients.
    Abiko T; Sekino H
    Mediators Inflamm; 1996; 5(4):295-8. PubMed ID: 18475743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of [Phe(4F)3]thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients.
    Abiko T; Sekino H
    Bioorg Med Chem; 1995 Oct; 3(10):1369-75. PubMed ID: 8564403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of human splenin (hSP) and examination of its immunological effects on the impaired T- and B-lymphocytes in uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):487-91. PubMed ID: 2337963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of [I-NaI3]] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes.
    Abiko T; Nakatsubo S
    Mediators Inflamm; 2000; 9(3-4):201-6. PubMed ID: 11132780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase syntheses of two deacetyl-thymosin alpha 1 analogues with substitution at position 21 and their effects on low E-rosette-forming lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1992; 3(3-4):159-68. PubMed ID: 1303729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of deacetylthymosin beta 11 and its effect on the impaired T-lymphocytes of a uremic patient with common variable immunodeficiency.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1988 Dec; 10(6):576-88. PubMed ID: 3266074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2647-52. PubMed ID: 1806285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of [Glu34]human splenin (hSP) and examination of its immunological effect on the reduced B-lymphocytes of uremic patients.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):391-6. PubMed ID: 2787213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological effect of two synthetic peptides containing alanine or D-alanine instead of acetyl group of thymosin beta 4 after treatment of human serum.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2602-5. PubMed ID: 2285992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis of peptides with potential thymic hormone activity: the synthesis of endo-Arg38a-deacetylthymosin beta 10.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1987 Feb; 9(1):20-30. PubMed ID: 3494463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of two deacetyl-thymosin beta4 analogs and their anti-inflammatory effect on carrageenin-induced edema in the mouse paw.
    Abiko T; Ogawa R
    Mediators Inflamm; 2001 Apr; 10(2):89-92. PubMed ID: 11405555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vitro.
    Ikemoto S; Kishimoto T; Wada S; Hayahara N; Maekawa M
    Clin Exp Immunol; 1990 Jun; 80(3):474-7. PubMed ID: 2372994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of deacetyl-thymosin beta 7 and examination of its immunological effect on the blastogenic response of T-lymphocytes of a uremic patient with cell-mediated immunodeficiency.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):700-7. PubMed ID: 3261642
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of prothymosin alpha deduced from nucleotide sequence of the murine cDNA and its effect on the impaired T lymphocytes of uremic patients.
    Abiko T; Sekino H
    Biotechnol Ther; 1993; 4(3-4):213-20. PubMed ID: 8292970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of an immunologically active fragment analog of prothymosin alpha with enhanced enzymatic stability.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):752-6. PubMed ID: 2070460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.